Food and Drug Administration agency to favor new physician endorsed drugs for the market, to think about a medication's value and cost aside from its safety and adequacy in that procedure. Shouldn't the cost of another medication reflect how its security and adequacy contrast with drugs as of now available? How does the asked for value contrast existing items with comparable signs for usage? Shouldn't there be government rules on prescription drug cost increments? Is it reasonable that pharmaceutical organizations, who have been granted huge numbers of their medications as a patent, to raise costs to such an extent and as regularly as they need? We should not to be shocked that the cost of numerous prescribed medications is expanding at high